2219 — Chaoju Eye Care Holdings Share Price
Last trade - 00:00- HK$2.16bn
- HK$718.02m
- CNY1.41bn
- 76
- 90
- 63
- 91
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 6.85 | ||
| PEG Ratio (f) | 0.44 | ||
| EPS Growth (f) | 18.39% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.85 | ||
| Price to Tang. Book | 1 | ||
| Price to Free Cashflow | 8.35 | ||
| Price to Sales | 1.4 | ||
| EV to EBITDA | 1.76 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 10.76% | ||
| Return on Equity | 8.34% | ||
| Operating Margin | 19.45% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 794.28 | 997.79 | 990.04 | 1,369.51 | 1,405.45 | 1,709.46 | 1,962.35 | 14.48% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +67.92 | +43.55 | +2.48 | +33 | -13.93 | +22.57 | +15.79 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Chaoju Eye Care Holdings Ltd is an investment holding company principally engaged in the provision of in-patient services, out-patient services, sales of optical products and sales of equipment and medical consumables. The Company operates in three segments. The Consumer Ophthalmic Services segment includes treatments and prevention of various types of ophthalmic disorders, including refractive correction, myopia prevention and control, dry eye syndrome, oculoplastic and provision of optical products and services. The Basic Ophthalmic Services segment include treatments of a wide range of common eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases and pediatric eye diseases. The Company also operates Sales of Equipment and Medical Consumables segment.
Directors
- Bozhou Zhang CHM (59)
- Weichao Wang CFO (40)
- Hongyan Liu COO (51)
- Fengsheng Zhang EDR
- Guangdi Zhang EDR (28)
- Junfeng Zhang EDR (55)
- Xiaoli Zhang EDR (60)
- Yajun Yang OTH (50)
- Ching Kit Cheng SEC (33)
- Mao Chen NED (52)
- Xian Ke NED (31)
- Zhen Li NED (42)
- Wenwen Zhang NED (38)
- Shan Bao NID (50)
- Hongyan Guo NID (57)
- Mingguang He NID (52)
- Jianbin Li NID (42)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 19th, 2020
- Public Since
- July 7th, 2021
- No. of Employees
- 2,608
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 707,510,500
- Address
- Block A, Shouke Building, BEIJING
- Web
- https://www.chaojueye.com/
- Phone
- Auditors
- Ernst & Young
Upcoming Events for 2219
Similar to 2219
Adicon Holdings
Stock Exchange of Hong Kong Limited
Aidigong Maternal & Child Health
Stock Exchange of Hong Kong Limited
Arrail
Stock Exchange of Hong Kong Limited
Suzhou Basecare Medical
Stock Exchange of Hong Kong Limited
Bayzed Health
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:52 UTC, shares in Chaoju Eye Care Holdings are trading at HK$3.05. This share price information is delayed by 15 minutes.
Shares in Chaoju Eye Care Holdings last closed at HK$3.05 and the price had moved by +3.04% over the past 365 days. In terms of relative price strength the Chaoju Eye Care Holdings share price has underperformed the FTSE Developed Asia Pacific Index by -9.85% over the past year.
The overall consensus recommendation for Chaoju Eye Care Holdings is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Chaoju Eye Care Holdings dividend yield is 8.45% based on the trailing twelve month period.
Last year, Chaoju Eye Care Holdings paid a total dividend of CNY0.23, and it currently has a trailing dividend yield of 8.45%. We do not have any data on when Chaoju Eye Care Holdings is to next pay dividends.
We do not have data on when Chaoju Eye Care Holdings is to next pay dividends. The historic dividend yield on Chaoju Eye Care Holdings shares is currently 8.45%.
To buy shares in Chaoju Eye Care Holdings you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$3.05, shares in Chaoju Eye Care Holdings had a market capitalisation of HK$2.16bn.
Here are the trading details for Chaoju Eye Care Holdings:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2219
Based on an overall assessment of its quality, value and momentum Chaoju Eye Care Holdings is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Chaoju Eye Care Holdings is HK$4.66. That is 52.72% above the last closing price of HK$3.05.
Analysts covering Chaoju Eye Care Holdings currently have a consensus Earnings Per Share (EPS) forecast of CNY0.37 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Chaoju Eye Care Holdings. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -12.72%.
As of the last closing price of HK$3.05, shares in Chaoju Eye Care Holdings were trading +5.66% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Chaoju Eye Care Holdings PE ratio based on its reported earnings over the past 12 months is 6.85. The shares last closed at HK$3.05.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Chaoju Eye Care Holdings' management team is headed by:
- Bozhou Zhang - CHM
- Weichao Wang - CFO
- Hongyan Liu - COO
- Fengsheng Zhang - EDR
- Guangdi Zhang - EDR
- Junfeng Zhang - EDR
- Xiaoli Zhang - EDR
- Yajun Yang - OTH
- Ching Kit Cheng - SEC
- Mao Chen - NED
- Xian Ke - NED
- Zhen Li - NED
- Wenwen Zhang - NED
- Shan Bao - NID
- Hongyan Guo - NID
- Mingguang He - NID
- Jianbin Li - NID